Your browser doesn't support javascript.
loading
Antifibrotic effect and long-term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus.
Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Mikami, Shigeru; Haruki, Uojima; Yoshikata, Keiichiro; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Nakagawa-Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Nagao, Mototsugu; Inagaki, Kyoko; Fukuda, Izumi; Sugihara, Hitoshi; Iwakiri, Katsuhiko.
Afiliação
  • Arai T; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Atsukawa M; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Tsubota A; Core Research Facilities for Basic Science, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.
  • Mikami S; Division of Gastroenterology, Department of Internal Medicine, Kikkoman General Hospital, Miyazaki Noda, Japan.
  • Haruki U; Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Yoshikata K; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Ono H; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Kawano T; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Yoshida Y; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Tanabe T; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Okubo T; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Hayama K; Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
  • Nakagawa-Iwashita A; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Itokawa N; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Kondo C; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Kaneko K; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
  • Nagao M; Division of Endocrinology, Diabetes and Metabolism, Nippon Medical School, Tokyo, Japan.
  • Inagaki K; Division of Endocrinology, Diabetes and Metabolism, Nippon Medical School, Tokyo, Japan.
  • Fukuda I; Division of Endocrinology, Diabetes and Metabolism, Nippon Medical School, Tokyo, Japan.
  • Sugihara H; Division of Endocrinology, Diabetes and Metabolism, Nippon Medical School, Tokyo, Japan.
  • Iwakiri K; Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Hepatol Commun ; 6(11): 3073-3082, 2022 11.
Article em En | MEDLINE | ID: mdl-36039537
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hepatol Commun Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hepatol Commun Ano de publicação: 2022 Tipo de documento: Article